270 related articles for article (PubMed ID: 30309359)
21. Immunological characterization of chimeras of high specificity antigens from Mycobacterium tuberculosis H37Rv.
Fatma F; Tripathi DK; Srivastava M; Srivastava KK; Arora A
Tuberculosis (Edinb); 2021 Mar; 127():102054. PubMed ID: 33550109
[TBL] [Abstract][Full Text] [Related]
22. Subunit vaccine candidate AMM down-regulated the regulatory T cells and enhanced the protective immunity of BCG on a suitable schedule.
Luo Y; Jiang W; Da Z; Wang B; Hu L; Zhang Y; An R; Yu H; Sun H; Tang K; Tang Z; Wang Y; Jing T; Zhu B
Scand J Immunol; 2012 Mar; 75(3):293-300. PubMed ID: 22117839
[TBL] [Abstract][Full Text] [Related]
23. A Promising Listeria-Vectored Vaccine Induces Th1-Type Immune Responses and Confers Protection Against Tuberculosis.
Yin Y; Lian K; Zhao D; Tao C; Chen X; Tan W; Wang X; Xu Z; Hu M; Rao Y; Zhou X; Pan Z; Zhang X; Jiao X
Front Cell Infect Microbiol; 2017; 7():407. PubMed ID: 29034213
[TBL] [Abstract][Full Text] [Related]
24. [Prokaryotic expression and immunological characteristics of Mycobacterium tuberculosis Rv1886c].
Tao C; Zhao D; Dong H; Shan F; Lian K; Pan Z; Chen X; Yin Y; Jiao X
Wei Sheng Wu Xue Bao; 2014 Mar; 54(3):330-7. PubMed ID: 24984525
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
[TBL] [Abstract][Full Text] [Related]
26. Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy.
Dietrich J; Aagaard C; Leah R; Olsen AW; Stryhn A; Doherty TM; Andersen P
J Immunol; 2005 May; 174(10):6332-9. PubMed ID: 15879133
[TBL] [Abstract][Full Text] [Related]
27. Alarmin IL-33 elicits potent TB-specific cell-mediated responses.
Villarreal DO; Siefert RJ; Weiner DB
Hum Vaccin Immunother; 2015; 11(8):1954-60. PubMed ID: 26091147
[TBL] [Abstract][Full Text] [Related]
28. A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice.
Li W; Deng G; Li M; Zeng J; Zhao L; Liu X; Wang Y
Mol Immunol; 2014 Nov; 62(1):86-95. PubMed ID: 24980867
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
Deng YH; He HY; Zhang FJ
Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
[TBL] [Abstract][Full Text] [Related]
30. Sequential pulmonary immunization with heterologous recombinant influenza A virus tuberculosis vaccines protects against murine M. tuberculosis infection.
Muflihah H; Flórido M; Lin LCW; Xia Y; Triccas JA; Stambas J; Britton WJ
Vaccine; 2018 Apr; 36(18):2462-2470. PubMed ID: 29602704
[TBL] [Abstract][Full Text] [Related]
31. Immunogenicity and protective efficacy of recombinant Bacille Calmette-Guerin strains expressing mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70.
Dai FY; Wang JF; Gong XL; Bao L
Hum Vaccin Immunother; 2017 Jun; 13(6):1-8. PubMed ID: 28301284
[TBL] [Abstract][Full Text] [Related]
32. T-bet acts as a powerful adjuvant in Ag85B DNA‑based vaccination against tuberculosis.
Hu D; Wu J; Zhang R; Chen L
Mol Med Rep; 2012 Jul; 6(1):139-44. PubMed ID: 22552442
[TBL] [Abstract][Full Text] [Related]
33. Recombinant Bacillus subtilis spores for the delivery of Mycobacterium tuberculosis Ag85B-CFP10 secretory antigens.
Das K; Thomas T; Garnica O; Dhandayuthapani S
Tuberculosis (Edinb); 2016 Dec; 101S():S18-S27. PubMed ID: 27727129
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity and Protective Efficacy of a Fusion Protein Tuberculosis Vaccine Combining Five Esx Family Proteins.
Xiang ZH; Sun RF; Lin C; Chen FZ; Mai JT; Liu YX; Xu ZY; Zhang L; Liu J
Front Cell Infect Microbiol; 2017; 7():226. PubMed ID: 28620588
[TBL] [Abstract][Full Text] [Related]
35. Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice.
Stylianou E; Diogo GR; Pepponi I; van Dolleweerd C; Arias MA; Locht C; Rider CC; Sibley L; Cutting SM; Loxley A; Ma JK; Reljic R
Eur J Immunol; 2014 Feb; 44(2):440-9. PubMed ID: 24214530
[TBL] [Abstract][Full Text] [Related]
36. Enhanced immune response and protection efficacy of a DNA vaccine constructed by linkage of the Mycobacterium tuberculosis Ag85B-encoding gene with the BVP22-encoding gene.
Yao W; Liu S; Qu X; Xiao S; Liu Y; Liu J
J Med Microbiol; 2009 Apr; 58(Pt 4):462-468. PubMed ID: 19273642
[TBL] [Abstract][Full Text] [Related]
37. Enhanced delivery of Mycobacterium tuberculosis antigens to antigen presenting cells using RVG peptide.
Garnica O; Das K; Devasundaram S; Dhandayuthapani S
Tuberculosis (Edinb); 2019 May; 116S():S34-S41. PubMed ID: 31064713
[TBL] [Abstract][Full Text] [Related]
38. Vaccines displaying mycobacterial proteins on biopolyester beads stimulate cellular immunity and induce protection against tuberculosis.
Parlane NA; Grage K; Mifune J; Basaraba RJ; Wedlock DN; Rehm BH; Buddle BM
Clin Vaccine Immunol; 2012 Jan; 19(1):37-44. PubMed ID: 22072720
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of immune response to a DNA vaccine against Mycobacterium tuberculosis Ag85B by incorporation of an autophagy inducing system.
Meerak J; Wanichwecharungruang SP; Palaga T
Vaccine; 2013 Jan; 31(5):784-90. PubMed ID: 23228812
[TBL] [Abstract][Full Text] [Related]
40. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.
Kim A; Hur YG; Gu S; Cho SN
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
